Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Illumina Inc ILMN

Technology Scientific & Technical Instruments
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments... see more

Opinion & Analysis (NDAQ:ILMN)

    Illumina Shares Fall Sharply on Lower Revenue Guidance

    Streetwise Reports July 16, 2019

    3 Niche ETFs Breaking Out

    Benzinga.com  February 17, 2015

    The Calandra Report: X-Factor stocks

    Thom Calandra December 30, 2014

    Meet The 5 Companies Loving Obamacare

    Benzinga.com  November 4, 2014

    The Calandra Report: Roux New Orleans, parabola on our plates

    Thom Calandra October 29, 2014

    The Calandra Report: Shame on Barkerville and their dilutive ilk

    Thom Calandra February 28, 2014

    The Calandra Report: Watch this hot tub!

    Thom Calandra January 10, 2014

    The Calandra Report: Next billionaire companies, Inovio Pharma, Coastal Contacts

    Thom Calandra December 11, 2013

    The Calandra Report: Coastal Contacts, Inovio, Stockr and more at LD Micro

    Thom Calandra December 6, 2013

    The Calandra Report: Missing the boat on biotech while searching for rocks

    Thom Calandra November 21, 2013

    Giant company you've never heard of is breaking out

    Larsen Kusick July 10, 2010

    Great Panther, Animas, BioCryst: Ticker Trax Thom

    Thom Calandra November 25, 2009